Skip to main content
. 2018 Nov 14;2018:3165125. doi: 10.1155/2018/3165125

Table 2.

Demographic data and baseline characteristics.

Characteristics GMGHT group (n= 70) Placebo group (n= 73) p value
Sex (female), n (%) 67 (95.7) 62 (84.9) 0.05
Age 58.5 (8.7) 59.7 (7.5) 0.41
Height (m) 1.57 (0.06) 1.57 (0.07) 0.77
Body weight 59.1 (6.7) 62.3 (9.3) 0.02
BMI (kg/m2) 23.9 (2.2) 25.2 (4.2) 0.02
Duration of symptomatic OA (months) 51.7 (54.3) 61.4 (63.3) 0.33
Radiographic findings (Kellgren and Lawrence X-ray grade )
 Grade 2, n (%) 45 (64.3) 42 (57.5) 0.43
 Grade 3, n (%) 20 (28.6) 28 (38.4)
 Grade 4, n (%) 5 (7.1) 3 (4.1)
Patient's global assessment (0-100 VAS) 65.1 (17.5) 69.2 (13.0) 0.13
Patient's pain assessment (0-100 VAS) 68.4 (11.5) 71.0 (13.6) 0.22
Physician's global assessment (0-100 VAS) 65.7 (11.8) 68.1 (13.4) 0.28
WOMAC score
 Pain 11.1 (2.3) 11.3 (3.0) 0.70
 Stiffness 4.7 (1.3) 4.3 (1.4) 0.17
 Function 39.6 (10.0) 40.5 (9.6) 0.55
 Total 55.4 (12.7) 56.2 (12.9) 0.70

Values are presented as numbers (%) or mean (SD) unless otherwise stated.

BMI: body mass index, GMGHT: Gumiganghwal-tang, OA: osteoarthritis, SD: standard deviation, VAS: visual analog scale, WOMAC: the Western Ontario and McMaster Universities Arthritis Index.